Walmart has agreed to pay $50 million to resolve federal allegations that its pharmacies illegally filled thousands of invalid prescriptions for opioids and other controlled substances, ending a major federal case that dates back nearly six years.
The Justice Department and Drug Enforcement Administration announced the settlement on August 28. The government had accused Walmart of violating the Controlled Substances Act through actions involving both individual pharmacists and members of the retailer’s corporate compliance team.
